| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ebd2bf133f38ef4b26ddf180eb97791 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4826 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
| filingDate |
1999-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae7216b338610a469f428fc3ec103d42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ecd12997a76792a39230da3902cf497 |
| publicationDate |
2001-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6280728-B1 |
| titleOfInvention |
Treatment of hepatitis C virus infection using a protease and a flavonoid |
| abstract |
The use of at least one hydrolytic enzyme and at least one flavonoid shows better activity than α-interferon or ribavirin in the treatment of diseases caused by hepatitis C viruses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008004784-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101744830-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004100981-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7400961-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007031398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104762282-A |
| priorityDate |
1998-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |